SCHEMBL4501896

SCHEMBL4501896

CC(C)(C)OC(=O)N(N)C(=O)c1cc(F)c(F)cc1NC1CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 2/20 0.44
ROCK1 Q13464 1/20 0.35
HPGD P15428 1/20 0.34
GPR119 Q8TDV5 1/20 0.33
ALDH1A1 P00352 3/20 0.33
MELK Q14680 2/20 0.32
DPP4 P27487 1/20 0.32
NPC1 O15118 1/20 0.32
MAPT P10636 1/20 0.32
MAPK1 P28482 1/20 0.32
HTT P42858 1/20 0.32
RAB9A P51151 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
POLB P06746 1/20 0.32
APEX1 P27695 1/20 0.32
IRAK4 Q9NWZ3 3/20 0.32
GAA P10253 1/20 0.32
AAK1 Q2M2I8 2/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4515088 0.91 ROCK2 (0.39) ROCK2HPGDALDH1A1MELKIRAK4
SCHEMBL7559233 0.87 TSHR (0.40) ROCK2GPR119ALDH1A1MAPTHTT
SCHEMBL4512030 0.82 POLB (0.38) ROCK2ROCK1HPGDMELKPOLB
SCHEMBL7512228 0.82 KDM4D (0.33) ROCK2ALDH1A1HTTIRAK4
SCHEMBL7511353 0.81 AAK1 (0.36) ROCK2ALDH1A1HTTAAK1
SCHEMBL27566110 0.81 ROCK2 (0.51) ROCK2ROCK1HPGDALDH1A1MELK
SCHEMBL7552767 0.79 ALDH1A1 (0.34) ROCK2GPR119ALDH1A1DPP4MAPT
SCHEMBL7513215 0.78 ACACB (0.40)
SCHEMBL4515470 0.78 ALDH1A1 (0.33) ROCK2ALDH1A1DPP4MAPTHTT
SCHEMBL7559487 0.78 KDM4D (0.31) IRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7582627-B2 3-Amino-7-[3-(1-aminoethyl)-4-fluoropyrrolidin-1-yl]-1-cyclopropyl-8-methyl-1H-pyrido[4,3-d]pyrimidine-2,4-dione; quinolone antibiotics; bactericides; for antibiotic- resistant bacterial infections, ciprofloxacin- resistant ones; inhibiting wild-type and quinolone- resistant mutants of DNA gryase WARNER-LAMBERT COMPANY (US) 2009-09-01 US disclosed
EP-1255739-B1 3-AMINOQUINAZOLIN-2,4-DIONE ANTIBACTERIAL AGENTS WARNER LAMBERT CO (US) 2008-06-11 EP disclosed
US-20060287308-A1 3-Aminoquinazolin-2,4-dione antibacterial agents ZOETIS WLC LLC 2006-12-21 US disclosed
US-7094780-B1 3-aminoquinazolin-2,4-dione antibacterial agents WARNER LAMBERT COMPANY LLC (US) 2006-08-22 US disclosed
US-20060183762-A1 3-AMINOQUINAZOLIN-2,4-DIONE ANTIBACTERIAL AGENTS ZOETIS WLC LLC 2006-08-17 US disclosed
EP-1255739-A1 3-AMINOQUINAZOLIN-2,4-DIONE ANTIBACTERIAL AGENTS WARNER-LAMBERT COMPANY (US) 2002-11-13 EP disclosed
WO-2001053273-A1 3-AMINOQUINAZOLIN-2,4-DIONE ANTIBACTERIAL AGENTS WARNER-LAMBERT COMPANY (US) 2001-07-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060183762-A1 3-AMINOQUINAZOLIN-2,4-DIONE ANTIBACTERIAL AGENTS ABL1, NQO2, CBR3 ROCK2 2184/4885ROCK1 2756/4885HPGD 3238/4885
US-20060287308-A1 3-Aminoquinazolin-2,4-dione antibacterial agents ABL1, NQO2, AAAS ROCK2 2186/4885ROCK1 2640/4885HPGD 3335/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.